Waheed Nadia 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 24, 2026
Insider Transaction Report
Form 4
Waheed Nadia
Chief Medical Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-20$7.74/sh−3,510$27,167→ 314,907 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on June 1, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 11, 2026. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.6838 to $7.7900, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
/s/ Todd Anderman, Attorney-in-Fact for Nadia Waheed|2026-02-24